Pathogenesis of various forms of infection in artificial hearts

Pathophysiology

Volumn 9, Issue 3, 2003, Pages 161-178

  Dobšák, Petr ^a   Vašků, Jaromir ^b   Jančík, Jiří ^a   Eicher, Jean Christophe ^c   Wotke, Jirí ^a  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b Vacord Bioengineering Res Company   (Czech Republic)

^c HÔPITAL DU BOCAGE   (France)

Author keywords

Decreased host immune defense; Increased virulence slime biofilm depended; LVAD and TAH infections; Multi factorial pathogenesis; Multi factorial therapy

Indexed keywords

BIOMATERIAL; CHLORAMPHENICOL; COTRIMOXAZOLE; DOXYCYCLINE; FERRUMLEK; FLUNIXIN MEGLUMINE; GENTAMICIN; IRON SACCHARATE; NEOMYCIN; OXYTETRACYCLINE; PENICILLIN G; POLYMYXIN B; ROLITETRACYCLINE; STREPTOMYCIN; SULFADOXINE PLUS TRIMETHOPRIM; TETRAMISOLE; TOBRAMYCIN SULFATE; TYLOSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL HEART; BLOOD CLOTTING; BODY TEMPERATURE; CAUSE OF DEATH; CONTROLLED STUDY; COW; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; GOAT; GRAM POSITIVE BACTERIUM; HEMOLYSIS; HOST RESISTANCE; INFECTIOUS COMPLICATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS EPIDERMIDIS; SURVIVAL; THROMBOGENESIS; VIRULENCE;

EID: 0142059277     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4680(02)00082-2     Document Type: Article

References (58)

1. Richards G.K., Gagnon R.F. The continuing enigma of implant-associated infections. Int. J. Artif. Organs. 16:1993;747-748.
2. Burns G.L., Olsen D.B. Immune response changes with blood pump use in calves. ASAIO Trans. 35:1989;700-702.
3. Burns G.L., Olsen D.B. Patterns of bacterial infection in calves implanted artificial hearts. ASAIO Trans. 36:1990;M138-M140.
4. Chiang B.Y., Olsen D.B., Burns G.L., Pantalos G.M., Everett S., Dew P.A., Tatsumi E., Rowles J.R., Mohammad F. Thrombus with infection in total artificial heart animals. Artif. Organs. 16:1992;371-376.
5. Myers T.J., McGee M.G., Zeluff B.J., Radovancevic B., Frazier O.H. Frequency and significance of infections receiving prolonged LVAD support. ASAIO Trans. 37:1991;M283-M285.
6. McBride L.R., Swartz M.T., Reedy J.E., Miller L.W., Pennington D.G. Device related infections in patients supported with mechanical circulatory support devices for greater than 30 days. ASAIO Trans. 37:1991;M258-M259.
7. Springer W.E., Wasler A., Radovancevic B., Myers T.J., Odegard P., Macris M.P., Frazier O.H. Retrospective analysis of infection in patients undergoing support with left ventricular assist systems. ASAIO J. 42:(5):1996;763-765.
8. Fischer S.A., Trenholme G.M., Constanzo M.R., Piccione W. Infectious complications in left ventricular assist device recipients. Clin. Infect. Dis. 24:1997;18-23.
9. Herrmann M., Weyand M., Greshake B., von Eiff C., Proctor R.A., Scheld H.H., Peters G. Left ventricular assist device infection is associated with increased mortality but is not a contradiction to transplantation. Circulation. 95:1997;814-817.
10. Prendergast T.W., Todd B.A., Beyer A.J. III, Furukawa S., Eisen H.J., Addonizio V.P., Browne B.J., Leevanandam V. Management of left ventricular assist device infection with heart transplantation. Ann. Thorac. Surg. 64:1997;142-147.
11. Argenziano M., Catanese K.A., Moazami N., Gardocki M.T., Weinberg A.D., Clavenna M.W., Rose E.A., Scully B.E., Levin H.R., Oz M.C. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J. Heart Lung Transplant. 16:1997;822-831.
12. Moroney D.A., Vaca K.J. Infectious complications associated with ventricular assist devices. Am. J. Crit. Care. 4:1995;204-209. quiz 210-1.
13. McCarthy P.M., Schmitt S.K., Vargo R.L., Gordon S., Keys T.F., Hobbs R.E. Implantable LVAD infections: implications for permanent use of the device. Ann. Thorac. Surg. 61:1996;359-365. discussion 372-3.
14. Holman W.L., Murrah C.P., Fergusson E.R., Bourge R.C., McGriffin D.C., Kirklin J.K. Infections during extended circulatory support: University of Alabama at Birmingham experience 1989-1994. Ann. Thorac. Surg. 61:1996;366-371. discussion 372-3.
15. El-Banayosy A., Minami K., Arusoglu L., Fey O., Kizner L., Hartmann D., Kortke H., Korner M.M., Kleikamp G., Korfer R. Long-term mechanical circulatory support. Thorac. Cardiovasc. Surg. 45:1997;127-130.
16. Turowski G.A., Orgill D.P., Pribaz J.J., Eriksson E., Couper G.S. Salvage of externally exposed ventricular assist devices. Plast. Recons. Surg. 102:1998;2425-2430.
17. Gristina A.G., Dobbins J.J., Giammara B., Lewis J.C., DeVries W.C. Biomaterial-centered sepsis and the total artificial heart. Microbial adhesion vs. tissue integration. JAMA. 259:1988;870-874.
18. Arabia F.A., Copeland J.G., Smith R.G., Banchy M., Sethi G.K., Foy B., Kormos R., Tector A., Long J., Dembitsky W., Carrier M., Keon W., Pavie A., Duveau D. Infections with the Cardio/West total artificial heart. ASAIO J. 44:1998;M336-M339.
19. Kunin C.M., Dobbins J.J., Melo J.C., Levinson M.M., Love K., Joyce L.D., DeVries W. Infectious complications in four long-term recipients of the Jarvik - 7 artificial heart. JAMA. 259:1988;860-864.
20. Griffith B.P., Kormos R.L., Hardesty R.L., Armitage J.M., Dummer J.S. The artificial heart: infection-related morbidity and its effect on transplantation. Ann. Thorac. Surg. 45:1988;409-414.
21. Pennington D.G., McBride L.R., Miller L.W., Swartz M.T. Eleven years' experience with the Pierce-Donachy ventricular assist device. J. Heart Lung Transplant. 13:1994;803-810.
22. Copeland J.G., Tsau P.H., Arabia F.A., Xie T. Correlation of clinical embolic events with coagulability in a patient with a total artificial heart. J. Heart Lung Transplant. 14:1995;990-998.
23. Copeland J.G., Arabia F.A., Smith R.G., Sethi G.K., Nolan P.E., Banchy M.E. Arizona experience with Cardio-West Total artificial heart bridge to transplantation. Ann. Thorac. Surg. 68:1999;756-760.
24. Muneretto C., Solis E., Pavie A., Leger P., Gandjbakhch I., Szefner J., Bors V., Piazza C., Cabrol A., Cabrol C. Total artificial heart: survival and complications. Ann. Thorac. Surg. 47:1989;151-157.
25. Vašků J. Actual pathophysiological problems in the contemporary research on the TAH. Ann. Thorac. Cardiovasc. Surg. 2:1996;315-330.
26. Vašků J., Urbanek P. Constructional and functional characteristics of recent total artificial heart models TNS-Brno-VII, VIII and IX. Artif. Organs. 19:1995;535-543.
27. Vašků J. Perspectives of total artificial heart research as a valuable modelling system for general physiology and pathophysiology. Akutsu T., Koyanagi H. Heart Replacement - Artificial Heart 4. 1993;161-171 Springer, Tokyo.
28. Vašků J. Artificial heart: pathophysiology of the total artificial heart and of cardiac assist devices. Acta Fac. Med. Univ. Brunensis JE Purkyne Brno. 1982;397.
29. Vašků J. Brno experiments in long-term survival with total artificial heart. Acta Fac. Med. Univ. Brunensis JE Purkyne Brno. 1984;662.
30. Vašků J. A contribution to the assessment of pathophysiology in long-term total artificial heart recipients. Unger F. Assisted Circulation 3. 1989;340-376 Springer, Berlin, Heidelberg.
31. Vašků J., Urbánek P. Electronmicroscopic study of driving diaphragms in long-term survival with a total artificial heart. Artif. Organs. 19:1995;344-354.
32. Vašků V., Vašků J. The development of the pathophysiological concept of calciphylaxis in experiment and clinic. Pathophysiology. 7:2001;231-244.
33. Vašků J. Changes in total artificial heart driving diaphragms after long-term pumping. Akutsu T., Koyanagi H. Heart Replacement - Artificial Heart 5. 1996;53-65 Springer, Tokyo.
34. Vašků J., Dobšák P. Electronmicroscopic changes in selected vital organs after long-term total artificial heart pumping in animal experiments. Artif. Organs. 24:2000;966-976.
35. Petz L.D. Drug induced immune hemolysis. N. Engl. J. Med. 313:1985;510-511.
36. Murray K.D., Abbot T.M., Olsen D.B., Galbraith T.A., Howanitz E.P., Watson K.M., Lowe P.A., Myerowitz P.D. Correlation of gross and microscopic appearance of skin buttons in total artificial heart animals. ASAIO Trans. 36:1990;825-829.
37. Allan A., Graham T.R., Withington P.S., Salih V., Dasse K.A., Poirier V.L., Lewis C.T. Development of a polyurethane percutaneous access device for long-term vascular access. ASAIO Trans. 36:1990;M349-M351.
38. Jarvik R., Westaby S., Katsumata T., Pigott D., Evans R.D. LVAD power delivery: a percutaneous approach to avoid infection. Ann. Thorac. Surg. 65:1998;470-473.
39. Chiang B.Y., Burns G.L., Pantalos G.M., Dew P.A., Kinoshita M., White R.K., Mohammad S.F., Olsen D.B. Microbially infected thrombus in animals with total artificial hearts. ASAIO Trans. 37:1991;M256-M257.
40. Chiang B.Y., Olsen D.B., Burns G.L., Pantalos G.M., Everett S., Dew P.A., Tatsumi E., Rowles J.R., Mohammad F. Thrombus with infection in total artificial heart animals. Artif. Organs. 16:1992;371-376.
41. Bos H.M., de Boer R.A., Burns G.L., Mohammad S.F. Evidence that bacteria prefer to adhere thrombus. ASAIO J. 42:1996;M881-M884.
42. Baumgartner J.N., Cooper S.L. Bacterial adhesion on polyurethane surfaces conditioned with thrombus components. ASAIO J. 42:1996;M476-M479.
43. Burns G.L. Infections associated with implanted blood pumps. Int. J. Artif. Organs. 16:1993;771-776.
44. Al-Mondhiry H., Pae W.E., Miller C.A., Pierce W.S. Platelet and fibrinogen survival in calves implanted with artificial heart and ventricular assist device: correlation with autopsy findings. Thromb. Haemost. 67:1992;413-416.
45. Gristina A.G., Giridhar G., Gabriel B.L., Naylor P.T., Myrvik Q.N. Cell biology and molecular mechanisms in artificial device infections. Int. J. Artif. Organs. 16:1993;755-763.
46. Costerton J.W., Khoury A.E., Ward K.H., Anwar H. Practical measures to control device-related bacterial infections. Int. J. Artif. Organs. 16:1993;765-770.
47. Richards G.K., Gagnon R.F. An assay of Staphylococcus epidermidis biofilm responses to therapeutic agents. Int. J. Artif. Organs. 16:1993;777-787.
48. Gagnon R.F., Richards G.K. A mouse model of implant associated infections. Int. J. Artif. Organs. 16:1993;789-798.
49. Ankersmit H.J., Tugulea S., Spanier T., Weinberg A.D., Artrip J.H., Burke E.M., Flannery M., Mancini D., Rose E.A., Edwards N.M., Oz M.C., Itescu S. Activation-induced T-cell death and immune dysfunction after implantation of left ventricular assist device. Lancet. 354:1999;550-555.
50. Harasaki H., Fukamachi K., Benavides M., Mannos J., Wika K., Masiello A. A comprehensive hematologic study in calves with total artificial hearts. ASAIO J. 41:1995;M266-M271.
51. F.D. Quinn, K.A. Birkness, L.C. Kikuta-Oshima, G.W. Newman, E.M. Ribot, C.H. King, Genetic and tissue culture systems in the study of bacterial pathogenesis, in: E.W. Ades, S.A. Morse, R.F. Rest (eds.), Microbial pathogenesis and immune response, New York, Ann. NY Acad. Sci. 767 (1996) 19-25.
52. H. Smith, What happens in vivo to bacterial pathogens, in: E.W. Ades, S.A. Morse, R.F. Rest (eds.), Microbial pathogenesis and immune response, New York, Ann. NY. Acad. Sci 767 (1996) 77-92.
53. J. Gille, R.A. Swerlick, Integrins: role in cell adhesion and communication, in: E.W. Ades, S.A. Morse, R.F. Rest (eds.), Microbial pathogenesis and immune response, New York, Ann. NY Acad. Sci. 767 (1996) 93-106.
54. Kireeva S.G., Selitskaia R.P. Therapeutic pathomorphosis. Effect of immunostimulator levamisole on the morphology of specific inflammation under experimental conditions. Arkh. Patol. 44:1982;38-44. russian.
55. Liapon A.O., Lebedev K.A., Mashkilleison A.L. Study of the peripheral blood T-lymphocytes by the spontaneous and active 'rosette' method using levamisole. Biul. Eksp. Biol. Med. 89:1980;630-632.
56. Boguslawska-Jaworska J., Chybicka A., Pisarek J. The study of T-lymphocytes, granulocyte's phagocytic activity and adherent cells in patients with acute lymphoblastic leukemia during levamisol therapy. Arch. Immunol. Ther. Exp. (Warsz). 26:1978;855-858.
57. Kyatas M. Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients. Artif. Organs. 26:2002;492-496.
58. Vašků V. Staphylococcal skin infections. Remedia Klin. Mikrobiol. 3:1999;54-56.